SOURCE: bioMETRX

March 16, 2006 08:00 ET

bioMETRX, Inc. Commences Development of smartVEST™ Body Armor Enhancement System

New System to Extend Current Body Armor Protection That Utilizes Biometrics to Provide Immediate Medical Information for the Wounded

JERICHO, NY -- (MARKET WIRE) -- March 16, 2006 -- bioMETRX, Inc. (OTC BB: BMRX) announced that its wholly owned subsidiary, smartTOUCH Medical, Inc., has commenced development on an innovative new system specifically designed to improve the overall protection of body armor that soldiers and law enforcement officers depend on every day.

The smartVEST Body Armor Enhancement System™ is being designed to extend the protections of current body armor apparel. Body armor has proven effective at reducing potential catastrophic physical injury to law enforcement and military personnel. bioMETRX's system looks beyond the physical protection of these products by allowing the product to communicate vital information to field medical personnel, extending protection after injury.

The smartVEST Body Armor Enhancement System™ design calls for two modes of communications. The first is a chip that is embedded into the actual vest that allows field medical personnel to scan the vest and have immediate access to the serviceman's complete medical record. The second feature includes a wireless finger-scan capture device that allows field personnel to scan an injured soldier's finger in the field, and wirelessly recall vital medical data for on-the-spot assessment and treatment. The latter feature is necessary in case the chip in the body armor is compromised or the body armor is taken off and discarded after injury.

"Our company has already developed several finger-activated products for the consumer electronics and home security markets, including garage door openers and thermostats," notes Lorraine Yarde, COO of bioMETRX, Inc. "Unlike our other self-contained embedded products, our smartTOUCH Medical subsidiary is working on a broader range of applications-based products like smartVEST for the medical community. While our system will provide critical medical information to field personnel treating the wounded, it will be the heroes protecting us who will benefit by this extended protection," noted Ms. Yarde. . According to the company, the smartVEST Body Armor Enhancement System is expected to be ready for the marketplace early 2007. The body armor market is a $1.5 billion dollar annual industry in the United States and $15 Billion worldwide. The smartVEST Body Armor Enhancement System™ is being designed to integrate transparently with all body armor products currently on the market.

About bioMETRX, Inc.

bioMETRX, Inc., through its wholly owned subsidiaries, designs, develops and markets biometrics-based products to the consumer, health information, medical devices and small business markets under the common brand name -- smartTOUCH™. bioMETRX Technologies, Inc., which was acquired in May 2005, designs and engineers biometrics-based products for the home security, consumer electronics, medical products and patient medical information markets; smartTOUCH Consumer Products, Inc. tests and markets the company's biometrically secured garage door openers, thermostats, deadbolts and home alarm keypads, and smartTOUCH Medical, Inc. designs, tests and markets biometrically secured medical crash carts, rolling medicine carts, portable patient medical information devices and, security and retrieval systems for electronic medical records. bioMETRX, Inc.'s entire product line is branded under the trade name "smartTOUCH™." For more information on bioMETRX and/or the company's smartTOUCH line of products, including the Garage Door Opener, visit the Company website at http://www.biometrx.net

Safe Harbor Statement: Forward-looking statements in this release with respect to bioMETRX's business, financial condition and results of operations, as well as matters of timing and the prospective terms of the transaction described, are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements, including, but not limited to, certain delays beyond bioMETRX's control with respect to market acceptance of their technology and/or products, whether financing will be available, the effect of the application of acquisition accounting policies as well as certain other risk factors which are and may be detailed from time to time in bioMETRX's filings with the Securities and Exchange Commission.

Contact Information